Category Archives: Hormone Replacement Therapy

Reducing the Risk of Breast Cancer in Menopausal Women Dr. Robert Casper speaking at the Dinner With Scientists 2013. An article abouth the dinner may be found at: http://research.lunenfeld.ca/rssnews/?page=1991. By: SamuelLunenfeld … Continue reading →

Hometown Hero: Soldier pulls man from burning truck The American Red Cross is honoring some "Hometown Heroes." They're people and organizations who exemplify courage, kindness, and unselfish character. SSG Don... By: FOX21NewsColorado … Continue reading →

Dangerous teen trend increases fire danger CSFD said the red flag warnings should be taken seriously, and parents need to watch out for their kids' curiosity. FOX21 News, dedicated to providing releva... By: FOX21NewsColorado … Continue reading →

Breaking down the gun bills on the governor's desk Three gun control bills are currently sitting on Governor John Hickenlooper's desk tonight waiting for his signature. They are house bills 1224, 1228 and 1229. By: FOX21NewsColorado … Continue reading →

This report available from Research and Markets analyzes and evaluates the global market opportunity for transdermal hormone replacement and assesses the probable impact of evolving regulatory, economic and demand factors. Dublin, Ireland (PRWEB) March 20, 2013 For the past two decades, the healthcare industry has responded to this clinical need by developing, testing and marketing hormone replacement therapy (HRT) products. Because of their ease-of-use and dosing characteristics, drug developers are continuing to turn to transdermal delivery systems for HRT products. There are more than 40 million post-menopausal women in the United States alone, and this group is expected to grow by 50% by 2020. With the aging of the population worldwide, conditions and diseases such as menopause, osteoporosis and heart disease, which may benefit from hormone replacement therapy, are expected to become significantly more prevalent. The industry continues to attract interest in the form of new participants and products. While the global market continues to be dominated by the FDA-approved HRT products of major pharmaceutical firms, regional markets are a bit more competitive, and present unique challenges to transdermal HRT sector participants. Highlights: For more information please visit http://www.researchandmarkets.com/research/c4mvd9/transdermal Research and Markets Laura Wood, Senior Manager. Email: press(at)researchandmarkets(dot)com Phone: +35314151241 … Continue reading →

St. Patty's Preview - The Chairman FOX21's Craig Coffey mixes it up with a fun preview of St. Patrick's Day events in Southern Colorado. By: FOX21NewsColorado … Continue reading →

BEDMINSTER, NJ (TheStreet) -- NPS Pharmaceuticals (NPSP) has reacquired worldwide marketing rights to two approved drugs, most notably its short bowel syndrome therapy Revestive, from Takeda. Under terms of the re-worked deal, Takeda will receive $50 million in NPS Pharma stock in exchange for relinquishing ex-North America commercial rights to Revestive and Preotact, a thyroid hormone replacement therapy. NPS partnered with Nycomed for Preotact in 2004 and Revestive in 2007, and then Takeda acquired Nycomed in 2011. The drugs were sold back to NPS Pharma because they are no longer "strategic" to the company, according to spokesman Tobias Cottman. European regulators approved Revestive last August but Takeda had not yet launched the drug. That responsibility will now fall to NPS Pharma, which needs to build out a commercial operation in Europe while also remaining focused on selling the drug in the U.S., where it's known as Gattex. Read the rest here: NPS Pharma Buys Back Worldwide Rights To Short Bowel Syndrome Drug … Continue reading →

The risks of taking hormone replacement therapy pills for menopausal women include gallbladder surgery, a large French study suggests. Gallstone disease is common in developed countries and its complications are a major reason for hospital admissions. Among women, those over the age of 50 are at greatest risk of gallstone disease. Researchers in France analyzed data on 70,928 menopausal women who were asked about their use of estrogen hormone therapy every two years between 1992 and 2008. They were checking for an increased risk of gallbladder surgery, also called cholecystectomy and for complications of gallstones. "Over five years, about one cholecystectomy in excess would be expected in every 150 women using oral estrogen therapy without a progestagen, compared with women not exposed to menopausal hormone therapy," Dr. Antoine Racine of South Paris University and his co-authors said in Monday's issue of the Canadian Medical Association Journal. "Complicated gallstone disease should be added to the list of potential adverse events to be considered when balancing the benefits and risks associated with menopausal hormone therapy." In France, hormone therapy is usually given in patch or gel form on the skin rather than orally as is common in North America, the United Kingdom … Continue reading →

Foxy Moms "Go Green" pregnancy tips A local Springs mom shares suggested green living tips during pregnancy. Check out our weekly "Go Green" segment every Tuesday evening on FOX21 News at 6:30 ... By: FOX21NewsColorado … Continue reading →

Hormone Replacement Therapy Osteoporosis by NoMoreVitamins com Hormone Replacement Therapy Osteoporosis by nomorevitamins com. Uploaded by Sam Matters on Mar 14 2013. httpnomorevitaminscom Dont let diets and hype keep you from the truth There's another way no one has told you about the holistic way to stop your joint pain from every joint in your body without more drugs and without sideeffects Are you ready Less pain is often felt the first day even if you are on other pills httpnomorevitaminscom. By: Sam Matters … Continue reading →